Comparative Study of Cryoballoon versus Radiofrequency for Pulmonary Vein Isolation when Combined with vein of Marshall Ethanol Infusion for Paroxysmal Atrial Fibrillation.
Atrial fibrillation
Catheter ablation
Chemical ablation
Cryoballoon
Radiofrequency current
Journal
Journal of atrial fibrillation
ISSN: 1941-6911
Titre abrégé: J Atr Fibrillation
Pays: United States
ID NLM: 101514767
Informations de publication
Date de publication:
Historique:
received:
10
11
2019
revised:
12
12
2019
accepted:
11
01
2020
entrez:
22
5
2020
pubmed:
22
5
2020
medline:
22
5
2020
Statut:
epublish
Résumé
Ethanol infusion (EI) in the vein of Marshall (VOM) has multifactorial effects that could be synergistic to pulmonary vein isolation (PVI) in ablation of atrial fibrillation (AF). The efficacy of radiofrequency (RF) versus cryoablation when combined with a VOM-EI has never been investigated. The aim of this study is to evaluate outcome differences of AF ablation using RF versus cryoablation when combined with a VOM-EI. Consecutive patients (n=132) underwent catheter ablation of paroxysmal AF with either RF or cryoballoon (CB) for PVI combined with VOM-EI. Bi-directional conduction block at the mitral isthmus was attempted. The end-point was the freedom from any atrial arrhythmias documented after a blanking period of 90 days after the procedure. Kaplan-Meier estimates of the arrhythmia-free survival after 1 year were 63.8 (RF + VOM), and 82.7 % (CB + VOM), respectively. Comparison between CB + VOM versus RF + VOM reached a significance (p=0.0292). The periprocedural complication rate was comparable in both groups (5.0 % RF, 5.8 % CB; p=0.14) with a significant difference in the incidence of phrenic nerve palsy (0 % RF, 2.0 % CB; p<0.05). PVI with a CB had an increased freedom from AF recurrence compared to RF combined with VOM-EI. The present results suggest a potential additive effect of a VOM-EI to CB application.
Identifiants
pubmed: 32435354
doi: 10.4022/jafib.2253
pmc: PMC7237087
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2253Références
Heart Rhythm. 2016 Sep;13(9):1810-6
pubmed: 27154231
JAMA. 2014 Feb 19;311(7):692-700
pubmed: 24549549
Circulation. 2004 Nov 9;110(19):2996-3002
pubmed: 15520313
J Interv Card Electrophysiol. 2015 Nov;44(2):171-8
pubmed: 26115748
Heart Rhythm. 2011 Sep;8(9):1444-51
pubmed: 21457789
Heart Rhythm. 2013 Sep;10(9):1354-6
pubmed: 23867146
Europace. 2016 Feb;18(2):201-5
pubmed: 25995389
J Cardiovasc Electrophysiol. 2001 Jul;12(7):750-8
pubmed: 11469421
Europace. 2015 Feb;17(2):225-31
pubmed: 25186456
Europace. 2017 Oct 1;19(10):1681-1688
pubmed: 27702854
Europace. 2016 Jul;18(7):987-93
pubmed: 26705562
Circulation. 2015 Oct 6;132(14):1311-9
pubmed: 26283655
Heart Rhythm. 2005 May;2(5):464-71
pubmed: 15840468
Heart. 2010 Sep;96(17):1379-84
pubmed: 20801856
Heart Rhythm. 2009 Nov;6(11):1552-8
pubmed: 19786370
J Am Coll Cardiol. 2014 May 13;63(18):1892-901
pubmed: 24561151
Heart Rhythm. 2016 Apr;13(4):836-44
pubmed: 26681608
Eur Heart J. 2009 Mar;30(6):699-709
pubmed: 19109353
JACC Clin Electrophysiol. 2016 Nov;2(6):759-761
pubmed: 29759756
J Am Coll Cardiol. 2008 Jul 22;52(4):273-8
pubmed: 18634982
Europace. 2015 Mar;17(3):370-8
pubmed: 25643988
J Cardiol. 2019 Jun;73(6):497-506
pubmed: 30878353
Heart Rhythm. 2012 Aug;9(8):1207-15
pubmed: 22406143
N Engl J Med. 2012 Oct 25;367(17):1587-95
pubmed: 23094720
J Interv Card Electrophysiol. 2016 Mar;45(2):169-77
pubmed: 26698157
J Cardiol. 2017 Jan;69(1):11-15
pubmed: 27160710
Circ Arrhythm Electrophysiol. 2009 Feb;2(1):50-6
pubmed: 19756206
Am J Med Sci. 2017 Dec;354(6):586-596
pubmed: 29208256
Europace. 2014 May;16(5):660-7
pubmed: 24798957
Europace. 2012 Oct;14(10):1385-413
pubmed: 22923145
Circulation. 2005 Mar 8;111(9):1100-5
pubmed: 15723973
J Cardiovasc Electrophysiol. 2010 Sep;21(9):1038-43
pubmed: 20367658
Europace. 2006 Aug;8(8):573-82
pubmed: 16864612
Circulation. 2004 Jan 27;109(3):327-34
pubmed: 14707026